We are live on ! Find out more
ATRC icon

AtriCure

79 hedge funds and large institutions have $165M invested in AtriCure in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 12

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

13% more capital invested

Capital invested by funds: $146M → $165M (+$19.1M)

11% more funds holding

Funds holding: 7179 (+8)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
79
Holders Change
+8
Holders Change %
+11.27%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
14
Increased
39
Reduced
12
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
U
76
UBS
Switzerland
$6K +$5.66K +574 New
Manulife (Manufacturers Life Insurance)
77
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.94K +$1.12M +113,262 +34%
RFC
78
Russell Frank Company
Washington
$1K +$266 +27 +31%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$1K +$463 +47 New
MRM
80
Michael R. Murphy
-$7.48M -786,950 Closed
DM
81
Deerfield Management
New York
-$5.99M -630,000 Closed
Renaissance Technologies
82
Renaissance Technologies
New York
-$336K -35,320 Closed
OAM
83
Oxford Asset Management
United Kingdom
-$167K -17,617 Closed
JP Morgan Chase
84
JP Morgan Chase
New York
-$126K -13,297 Closed
PG
85
PEAK6 Group
Illinois
-$34 -3,600 Closed

ATRC Hedge Fund Activity: Q3 2013 in Review

79 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2013, worth a combined $165M — up 13% from $146M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ATRC positions and 6 closed out — a net gain of 8 holders — while 39 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $4.55M. The largest seller was Michael R. Murphy, exiting entirely with an estimated $7.48M sold.

  • 79 institutional investors held AtriCure (ATRC) as of Q3 2013, up from 71 in Q2 2013.
  • Funds reported $165M of AtriCure stock for Q3 2013, up 13% quarter-over-quarter.
  • 14 funds opened new AtriCure positions in Q3 2013 and 6 closed out, a net change of +8 holders.
  • The largest AtriCure buyer in Q3 2013 was Fidelity Investments, an estimated $4.55M added.
  • The largest AtriCure seller in Q3 2013 was Michael R. Murphy, an estimated $7.48M sold.

Based on aggregated 13F filings for Q3 2013.